Vitrolife
175
SEK
+2,4 %
Mindre end 1K følgere
VITR
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Finansielt overblik og estimater
Ownership
+2,4%
-11,84%
-18,6%
-18,22%
-29,38%
-13,11%
-36,91%
+32,38%
+2.751,56%
Vitrolife is a global provider of solutions in the field of reproductive health. The company develops, manufactures, and distributes medical devices and provides genetic testing services for IVF clinics and their patients. Its mission is to support IVF clinics in enhancing their practice as well as the outcome of a patient’s fertility treatment. Vitrolife´s products and services are available globally, and the company is headquartered in Gothenburg, Sweden.
Læs mereMarkedsværdi
23,7 mia. SEK
Aktieomsætning
37,35 mio. SEK
Omsætning
3,61 mia.
EBIT %
21,7 %
P/E
46,17
Udbytteafkast, %
0,63 %
Finanskalender
24.4
2025
Delårsrapport Q1'25
29.4
2025
Generalforsamling '25
30.4
2025
Årligt udbytte
Alle
Selskabsmeddelelser
Eksterne analyser
ViserAlle indholdstyper
Vitrolife AB (publ): The Vitrolife Group appoints Ermanno Sironi as Chief Operating Officer
Redeye: Vitrolife Update - Modest stable growth with great margins
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools